BioHarvest Sciences Inc. Common Stock (BHST) Stock Forecast & Price Target
BioHarvest Sciences Inc. Common Stock · OTCQB
$2.02-0.03 (-1.46%)
15-min delayed · Aug 25, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering BioHarvest Sciences Inc. Common Stock, 2 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $5.00 to $8.00, a moderate spread. The average target of $6.50 sits 222% above the current $2.02. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 1 to 2 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.08 next quarter toward $-0.11 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Strong Buy
Strong Buy00%
Buy2100%
Hold00%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to BioHarvest Sciences Inc. Common Stock.
As of Aug, 2 of 2 firms rate BHST a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
BHST EPS & revenue forecast
EPS · NEXT QUARTER
$-0.08
Range $-0.10 – $-0.07 · 3 analysts · -20% YoY
Next period, 3 analysts expect BioHarvest Sciences Inc. Common Stock to earn $-0.08 a share (range $-0.10 – $-0.07), versus $-0.10 a year earlier. Full-year consensus is $-0.41, growing to $-0.11 the year after.
REVENUE · NEXT QUARTER
$10.9M
Range $10.9M – $10.9M · 3 analysts · +21% YoY
Revenue is expected to reach $10.9M (range $10.9M – $10.9M), +20.7% year-over-year. Full-year consensus is $37.4M, rising to $58.9M next year.
Top analysts covering BioHarvest Sciences Inc. Common Stock
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BHST.
#1
Anthony Vendetti
Maxim Group · Rank #350
Buy
$5.00+147.5% to target
Overall win rate
29%
+ Follow
#2
Sean McGowan
Roth MKM · Rank #380
Buy
$8.00+296.0% to target
Overall win rate
27%
+ Follow
#3
Amit Dayal
HC Wainwright & Co. · Rank #392
Buy
$14.00+593.1% to target
Overall win rate
26%
+ Follow
BHST stock forecast FAQ
What is BHST's average 12-month price target?+
The 2 analysts with a live target average $6.50 for BioHarvest Sciences Inc. Common Stock over the next 12 months, ranging from a $8.00 high to a $5.00 low.
Is BHST stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 2 analyst ratings, 2 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for BHST?+
The Street-high target is $8.00 (Roth Capital), and the Street-low is $5.00 (Maxim Group). The average of all 2 active targets is $6.50.
How many Wall Street analysts cover BHST?+
2 analysts have an active rating on BioHarvest Sciences Inc. Common Stock, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering BHST?+
Among analysts who currently cover BHST, Anthony Vendetti of Maxim Group has the strongest overall Quantellect track record (Rank #350). Their current call is Buy with a $5.00 target.
What is BioHarvest Sciences Inc. Common Stock's projected EPS for next quarter?+
The consensus estimate is $-0.08 per share (range $-0.10 – $-0.07) across 3 analysts. Full-year EPS is projected at $-0.41, rising to $-0.11 the following year.
How much revenue is BioHarvest Sciences Inc. Common Stock expected to report next quarter?+
Consensus revenue is $10.9M (range $10.9M – $10.9M). Full-year revenue is projected at $37.4M, growing to $58.9M next year.
Have analysts been upgrading or downgrading BHST lately?+
As of Aug, 2 of 2 firms rate BHST a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BHST calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
